TIMOTHY E. MORRIS - 16 Aug 2022 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
Director
Signature
/s/ Lori Braender, as Attorney-In-Fact
Issuer symbol
AQST
Transactions as of
16 Aug 2022
Net transactions value
$0
Form type
4
Filing time
17 Aug 2022, 15:35:02 UTC
Previous filing
29 Jul 2022
Next filing
23 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AQST Non-Qualified Stock Option (right to buy) Award $0 +28,500 $0.000000 28,500 16 Aug 2022 Common Stock 28,500 $1.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted under the Company's 2018 Equity Incentive Plan, which meets the requirements of Rule 16b-3. The options will vest in three annual installments with 1/3% on the 1st installment, 1/3% on the 2nd installment and 1/3% on the 3rd installment.